Dishman Carbogen Amcis Ltd - Stock Valuation and Financial Performance

BSE: 540701 | NSE: DCAL | Pharmaceuticals & Drugs | Small Cap

Dishman Carbogen Amc Share Price

218.15 -2.40 -1.09%
as on 21-Nov'24 16:00

DeciZen - make an informed investing decision on Dishman Carbogen Amc

Overall Rating
Bole Toh

1. Quality

2. Valuation

Somewhat Undervalued

3. Price Trend

Dishman Carbogen Amcis stock performance -

mw4me loader
P/E Ratio (CD):
0.00
Market Cap:
3,457.9 Cr.
52-wk low:
132.8
52-wk high:
283

Is Dishman Carbogen Amcis Ltd an attractive stock to invest in?

1. Is Dishman Carbogen Amcis Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dishman Carbogen Amcis Ltd is a below average quality company.

2. Is Dishman Carbogen Amcis Ltd undervalued or overvalued?

The key valuation ratios of Dishman Carbogen Amcis Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Dishman Carbogen Amcis Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Dishman Carbogen Amcis Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Dishman Carbogen Amc:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dishman Carbogen Amcis Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 0%0%4.6%4.7%5.8%3.9%-0.3%0.8%0.4%-0%-
Value Creation
Index
NANA-0.7-0.7-0.6-0.7-1.0-1.0-1.0-1.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 001,7141,6952,0592,0441,9122,1412,4132,6162,619
Sales YoY Gr.-NANA-1.1%21.5%-0.7%-6.4%12%12.7%8.4%-
Adj EPS 00010.213.810.9-8.91.92.7-8.9-11.1
YoY Gr.-NANANA35.2%-21.2%-181.9%NA42.5%-435.5%-
BVPS (₹) 000316.4333.3364.3363.5353.9370.5358.9365.9
Adj Net
Profit
00159165223171-14029.241.5-139-174
Cash Flow from Ops. 00303226282585513355266384-
Debt/CF from Ops. 003.14.83.71.82.346.95.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA4.9%11%8.4%
Adj EPS NA-191.5%NA-435.5%
BVPSNA1.5%-0.4%-3.1%
Share Price - 12.7% -1.5% 26.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
003.33.34.33.1-2.50.50.7-2.4-3.1
Op. Profit
Mgn %
0026.626.927.925.215.215.51610.710.7
Net Profit
Mgn %
008.49.810.98.4-7.31.41.7-5.3-6.7
Debt to
Equity
00238.60.20.20.20.20.30.30.40.2
Working Cap
Days
000339308332346279254241127
Cash Conv.
Cycle
000139127142155141156157-19

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 11.01%

Return on Equity is Poor

Sales growth is not so good in last 4 quarters at 3.63%

Latest Financials - Dishman Carbogen Amcis Ltd.

Standalone Consolidated
TTM EPS (₹) -2.5 -11.1
TTM Sales (₹ Cr.) 395 2,619
BVPS (₹.) 258 365.9
Reserves (₹ Cr.) 4,014 5,705
P/BV 0.85 0.60
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 132.75 / 282.95
All Time Low / High (₹) 46.45 / 396.55
Market Cap (₹ Cr.) 3,458
Equity (₹ Cr.) 31.4
Face Value (₹) 2
Industry PE 43

Management X-Ray of Dishman Carbogen Amc:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Dishman Carbogen Amc

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales1,7141,6952,0592,0441,9122,1412,4132,616
Operating Expenses 1,2601,2571,5071,5461,6381,8152,0812,352
Manufacturing Costs148132171178160207259314
Material Costs329337404459468447517597
Employee Cost 5966257157628739811,0301,208
Other Costs 187162217147137179275233
Operating Profit 453438552498274326332264
Operating Profit Margin (%) 26.5%25.8%26.8%24.3%14.3%15.2%13.8%10.1%
Other Income 2653544439492851
Interest 49495762485786120
Depreciation 214211240283308308281311
Exceptional Items 0000-22-15-48-6
Profit Before Tax 216231309197-65-4-55-122
Tax 71769839100-22-2531
Profit After Tax 145155210159-16518-30-153
PAT Margin (%) 8.5%9.1%10.2%7.8%-8.6%0.8%-1.2%-5.9%
Adjusted EPS (₹)0.09.613.010.1-10.51.2-1.9-9.8
Dividend Payout Ratio (%)0%0%2%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 45,1075,3795,7155,6995,5495,8105,628
Share Capital 032323131313131
Reserves 45,0755,3475,6845,6675,5185,7785,596
Minority Interest00000000
Debt8459188839301,0461,2551,7271,866
Long Term Debt4605253622415047621,047246
Short Term Debt3853935206885424936811,620
Trade Payables86186195284169193220244
Others Liabilities 5,6409578641,2651,4411,6371,6831,833
Total Liabilities 6,5747,1697,3218,1938,3568,6349,4399,571

Fixed Assets

Gross Block6,1876,6216,8977,8918,1558,6339,45810,308
Accumulated Depreciation1,3401,5601,8052,2182,4622,8653,2753,588
Net Fixed Assets4,8475,0615,0925,6735,6935,7686,1836,720
CWIP 1331511752344867801,043646
Investments 40196167191172324249102
Inventories427485549581516645804883
Trade Receivables286444445577421473590461
Cash Equivalents 876996161308172189413
Others Assets755764796776760472381345
Total Assets 6,5747,1697,3218,1938,3568,6349,4399,571

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 303226282585513355266384
PBT 216231309197-65-4-55-122
Adjustment 232235277330313325392381
Changes in Working Capital -29-206-17413231690-38144
Tax Paid -116-34-130-74-51-56-34-19
Cash Flow From Investing Activity -142-297-169-442-380-619-494-230
Capex -139-205-308-409-365-455-618-303
Net Investments 3-14868-2821-171104150
Others -65671-6-36821-76
Cash Flow From Financing Activity -13778-102-98-11130250-22
Net Proceeds from Shares -10000000
Net Proceeds from Borrowing -98118-172-15416928216750
Interest Paid -52-49-57-61-53-60-73-99
Dividend Paid -1900-30000
Others 338127121-127-9215626
Net Cash Flow 2371146122-13322132
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)3654.026.054.012.86-2.890.32-0.52-2.68
ROCE (%)4.64.675.793.93-0.260.760.43-0.03
Asset Turnover Ratio0.260.250.280.260.230.250.270.28
PAT to CFO Conversion(x)2.091.461.343.68N/A19.72N/AN/A
Working Capital Days
Receivable Days6179799195768073
Inventory Days91989210110599110118
Payable Days95147172190177148146142

Dishman Carbogen Amcis Ltd Stock News

Dishman Carbogen Amcis Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Dishman Carbogen Amc on 21-Nov-2024 16:00 is ₹218.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:00 the market cap of Dishman Carbogen Amc stood at ₹3,457.9.
The latest P/E ratio of Dishman Carbogen Amc as of 21-Nov-2024 16:00 is 0.00.
The latest P/B ratio of Dishman Carbogen Amc as of 21-Nov-2024 16:00 is 0.85.
The 52-week high of Dishman Carbogen Amc is ₹282.9 and the 52-week low is ₹132.8.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dishman Carbogen Amc is ₹394.8 ( Cr.) .

About Dishman Carbogen Amcis Ltd

Incorporated in 1983, Dishman Carbogen Amcis Limited (DCAL) started out as a manufacturer of quaternary ammonium and phosphate compounds. Having ventured into the CRAMS space in India, the company soon became one of the fastest growing companies. Today, the company is a leading global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up, and manufacturing services.

The company aids drug innovators for development and process optimization for novel drug molecules in various stages of the development process. Once the innovative molecules are approved, the company further explore the possibility of large scale commercial supply tie-ups. The company is generating a healthy pipeline of contract manufacturing opportunities commensurate to the growing revenue base of manufacturing. Its robust business model is capable of sustaining growth, with CRAMS being the focal point of all its strategic efforts.

Business area of the company

The company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies.

Products and services

  • CRAMS
  • Vitamin D & Analogues
  • Disinfectants
  • Highly Potent API Supply
  • Niche Generic API
  • Speciality Chemicals

History and Milestones

  • 1983: Incorporation of Dishman Pharmaceutical and Chemicals Limited.
  • 1989: Commencing production of Phase Transfer Catalysts at Naroda facility.
  • 1995: Entered into a JV with Schutz & Co. for manufacturing Chlorhexidine and Derivatives for European market.
  • 1996: Commencement of Bavla facility for Bulk Intermediates.
  • 2001: First commercial contract manufacturing agreement signed with a major western pharmaceutical company.
  • 2004: Came out with an IPO on Indian stock exchanges.
  • 2005: Acquisition of Synprotec - DCR (now known as CARBOGEN AMCIS Ltd, UK).
  • 2006: Acquisition of CARBOGEN AMCIS - a Swiss based CRAMS player.
  • 2007: Acquisition of Solvay Pharmaceuticals’ Vitamins and Chemicals business (now known as CARBOGEN AMCIS BV).
  • 2010: Commenced Dishman Shanghai manufacturing facility.
  • 2012: Acquisition of Riom (France) - CARBOGEN AMCIS SAS.
  • 2014: Acquisition of Vionnaz (CH) site - CARBOGEN AMCIS.
  • 2017: Change of name of the parent to Dishman Carbogen Amcis Limited, reinforcing the synergies between Dishman and Carbogen Amcis brands.
  • 2020: Global Reorganization of Roles and Responsibilities of the Management Team.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.